ZA921111B - (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins. - Google Patents
(Carboxyl) alkyloxyalkyl derivatives of cyclodextrins.Info
- Publication number
- ZA921111B ZA921111B ZA921111A ZA921111A ZA921111B ZA 921111 B ZA921111 B ZA 921111B ZA 921111 A ZA921111 A ZA 921111A ZA 921111 A ZA921111 A ZA 921111A ZA 921111 B ZA921111 B ZA 921111B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyclodextrins
- carboxyl
- alkyloxyalkyl
- derivatives
- alkyloxyalkyl derivatives
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91200319 | 1991-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA921111B true ZA921111B (en) | 1993-08-16 |
Family
ID=8207519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA921111A ZA921111B (en) | 1991-02-15 | 1992-02-14 | (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins. |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP0499322A1 (de) |
JP (1) | JPH06505039A (de) |
AU (1) | AU657304B2 (de) |
CA (1) | CA2104097A1 (de) |
FI (1) | FI933588A (de) |
HU (1) | HUT64979A (de) |
IE (1) | IE920485A1 (de) |
IL (2) | IL100856A (de) |
MX (1) | MX9200643A (de) |
NO (1) | NO932903L (de) |
NZ (1) | NZ241449A (de) |
WO (1) | WO1992014762A1 (de) |
ZA (1) | ZA921111B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2053399B1 (es) * | 1993-01-11 | 1995-02-16 | Univ Madrid Complutense | Procedimiento para la obtencion de derivados de beta-ciclodextrina. |
DE4428654A1 (de) * | 1994-08-12 | 1996-02-15 | Consortium Elektrochem Ind | Wasserlösliche Cyclodextrinderivate mit lipophilen Substituenten und Verfahren zu ihrer Herstellung |
DE69733664T3 (de) | 1996-04-19 | 2011-04-14 | Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles | Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen |
US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
JP6154163B2 (ja) * | 2013-03-15 | 2017-06-28 | 独立行政法人国立高等専門学校機構 | 水不溶性シクロデキストリンポリマーおよびその製造方法 |
CN103554307B (zh) * | 2013-09-25 | 2017-01-11 | 南京师范大学 | 羧甲基‑羟丙基‑β‑环糊精及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0146841A3 (de) * | 1983-12-17 | 1986-11-20 | Consortium für elektrochemische Industrie GmbH | Wasserlösliche Mischether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung |
NZ225045A (en) * | 1987-07-01 | 1990-06-26 | Janssen Pharmaceutica Nv | Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent |
-
1992
- 1992-02-03 IL IL100856A patent/IL100856A/en not_active IP Right Cessation
- 1992-02-05 NZ NZ241449A patent/NZ241449A/en unknown
- 1992-02-07 CA CA002104097A patent/CA2104097A1/en not_active Abandoned
- 1992-02-07 EP EP92200341A patent/EP0499322A1/de active Pending
- 1992-02-07 HU HU9302345A patent/HUT64979A/hu unknown
- 1992-02-07 AU AU11920/92A patent/AU657304B2/en not_active Ceased
- 1992-02-07 WO PCT/EP1992/000301 patent/WO1992014762A1/en not_active Application Discontinuation
- 1992-02-07 EP EP92903811A patent/EP0571416A1/de not_active Withdrawn
- 1992-02-07 JP JP4503791A patent/JPH06505039A/ja active Pending
- 1992-02-14 MX MX9200643A patent/MX9200643A/es unknown
- 1992-02-14 IE IE048592A patent/IE920485A1/en unknown
- 1992-02-14 ZA ZA921111A patent/ZA921111B/xx unknown
-
1993
- 1993-08-13 FI FI933588A patent/FI933588A/fi unknown
- 1993-08-16 NO NO93932903A patent/NO932903L/no unknown
-
1996
- 1996-07-11 IL IL11883896A patent/IL118838A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU1192092A (en) | 1992-09-15 |
FI933588A0 (fi) | 1993-08-13 |
AU657304B2 (en) | 1995-03-09 |
IL100856A0 (en) | 1992-11-15 |
NZ241449A (en) | 1993-06-25 |
FI933588A (fi) | 1993-08-13 |
WO1992014762A1 (en) | 1992-09-03 |
NO932903D0 (no) | 1993-08-16 |
HU9302345D0 (en) | 1993-10-28 |
IE920485A1 (en) | 1992-08-26 |
CA2104097A1 (en) | 1992-08-16 |
IL118838A0 (en) | 1996-10-31 |
MX9200643A (es) | 1992-10-01 |
IL100856A (en) | 1998-03-10 |
NO932903L (no) | 1993-08-16 |
JPH06505039A (ja) | 1994-06-09 |
HUT64979A (en) | 1994-03-28 |
EP0571416A1 (de) | 1993-12-01 |
EP0499322A1 (de) | 1992-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU653734B2 (en) | Substituted 4-biphenylmethoxypyridine derivatives | |
AU2280592A (en) | New heterocyclic derivatives | |
ZA924746B (en) | Substituted 1h-3-aryl-pyrrolidine-2,4-dione derivatives | |
EP0710673A3 (de) | Derivate von Cyclodextrinen | |
AU1655192A (en) | Antivizal dibenzothiazepinone derivatives | |
GR3023621T3 (en) | 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives | |
AU2706292A (en) | Heterobiaryl derivatives | |
AU1632192A (en) | Benzofuran derivatives | |
HU9203994D0 (en) | Imidazo-pyridine derivatives | |
AU1604492A (en) | Indole derivatives | |
AU2856692A (en) | Cephalosporin derivatives | |
AU1632092A (en) | Benzofuran derivatives | |
ZA928742B (en) | Heterocyclic derivatives. | |
ZA929934B (en) | Heterocyclic derivatives. | |
AU2630592A (en) | Point level detector | |
AU2544092A (en) | Carboxylic polysaccharide derivatives | |
ZA921111B (en) | (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins. | |
AU1033992A (en) | 3-quinuclidine derivatives | |
OA09716A (en) | Benzoxaiole derivatives. | |
EP0520435A3 (en) | Dc-89 derivatives | |
AU8769291A (en) | Deoxyhypusyl hydroxylase inhibitors | |
HU9201889D0 (en) | New cephem derivatives | |
AU1732692A (en) | Substituted imidazolinylpyrimidines | |
AU2686592A (en) | Tetraphenylporphyn derivatives | |
AU1627692A (en) | Benzofuran derivatives |